from DealZone:

Deals wrap: Bid for ING Direct USA

June 7, 2011

General Electric and Capital One have submitted bids for ING's U.S. online banking operations in a deal worth about $9 billion, Bloomberg reports.

from DealZone:

Deals wrap: Nasdaq, ICE drop NYSE bid

May 16, 2011

Nasdaq OMX and IntercontinentalExchange (ICE) dropped their $11.1 billion bid for rival exchange NYSE Euronext after it became clear the deal would not gain approval from U.S. antitrust regulators. The companies first offered to buy the New York Stock Exchange parent on April 1, aiming to curb a proposed friendly merger with Deutsche Boerse that was worth $10.2 billion when first announced in February. Deutsche Boerse responded to the news of the dropped bid by saying it plans to continue to pursue a merger with the Big Board parent.

from DealZone:

Deals wrap: GE to slow M&A warpath

March 29, 2011

General Electric Co Chairman & CEO Jeff Immelt talks to the media before speaking at the Detroit Economic Club in Birmingham, Michigan June 26, 2009. REUTERS/Rebecca CookGeneral Electric continued on its M&A warpath with a $3.2 billion agreement to acquire France’s Coverteam, a maker of automation systems used in the oil and gas sector, marking the latest in a series of deals in the energy industry. But, after some $11 billion in acquisitions in the energy sector over the past six months, GE plans to slow its pace of dealmaking, a top executive said.

from DealZone:

Deals wrap: An all-Japan exchange?

March 10, 2011

A man walks past a glass wall with logos of the Tokyo Stock Exchange at the bourse in Tokyo November 4, 2010. REUTERS/Yuriko Nakao Call it the survival instinct. The flurry of mergers and alliances underway in the global exchanges industry has served as a call to action for the Tokyo Stock Exchange, which may begin merger talks with its main Japanese rival Osaka Securities Exchange as it seeks out ways to survive consolidation sweeping the sector.

from DealZone:

Deals wrap: Key facts about the Sanofi/Genzyme deal

February 16, 2011

Chris Viehbacher, CEO of Sanofi-Aventis, gestures as he speaks during a news conference to present Sanofi-Aventis' 2010 annual results in Paris February 9, 2011.   REUTERS/Charles Platiau  French drugmaker Sanofi-Aventis agreed to buy Genzyme with a sweetened $20.1 billion cash offer, plus payments tied to the success of the U.S. biotech group's drugs, the companies said. Reuters has a factbox about the two companies, a timeline of Sanofi's quest for Genzyme and a look at Sanofi's patient CEO.

from DealZone:

DealZone Daily

December 21, 2009

"Saab story ends" we wrote on these pages last week. Now it has begun again, after Dutch luxury carmaker Spyker raised a last-minute bid over the weekend. It looks as if there are other options, with General Motors saying it will look into several new expressions of interest for its Swedish unit. That's only two days after it said it would start an orderly wind-down.

from Funds Hub:

Phew, the Gartmore “will it, won’t it” game is over!

November 20, 2009

 

SO: Gartmore is going ahead with a listing on the LSE after all, ending a "will it- won't it" game that has gone on for quite a bit in the past few weeks. Phew!